Yi Hu
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 118
- Cancer Immunotherapy and Biomarkers 46
- Lung Cancer Research Studies 29
- Colorectal Cancer Treatments and Studies 13
-
- Lung Cancer Treatments and Mutations 43
- Lung Cancer Diagnosis and Treatment 13
- Ferroptosis and cancer prognosis 12
- Co-authors
- Yangzhe Wu (9 shared papers)Haitao Tao (40 shared papers)Jinliang Wang (28 shared papers)Shunchang Jiao (20 shared papers)Yixue Xue (12 shared papers)Yijia Li (4 shared papers)Sujie Zhang (15 shared papers)Zhibo Zhang (14 shared papers)
- Journals
- Frontiers in Oncology (16 papers)Journal of Clinical Oncology (16 papers)Cancer Medicine (7 papers)Translational Lung Cancer Research (7 papers)Frontiers in Immunology (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yi Hu
294 papers receiving 5.1k citations
Yi Hu's Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 1.7k
- Cancer Research 869
- Immunology 755
- Pulmonary and Respiratory Medicine 809
- Molecular Biology 1.6k
Countries citing papers authored by Yi Hu
This map shows the geographic impact of Yi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Hu more than expected).
Fields of papers citing papers by Yi Hu
This network shows the impact of papers produced by Yi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Hu. The network helps show where Yi Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 313 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer Hit paper breakdown → | 2021 | 273 |
| 2 | Programmed Cell Death Tunes Tumor Immunity Hit paper breakdown → | 2022 | 243 |
| 3 | γδ T cells: origin and fate, subsets, diseases and immunotherapy Hit paper breakdown → | 2023 | 188 |
| 4 | 2015 | 116 | |
| 5 | 2019 | 112 | |
| 6 | 2015 | 104 | |
| 7 | 2010 | 97 | |
| 8 | 2019 | 94 | |
| 9 | 2018 | 92 | |
| 10 | 2021 | 91 | |
| 11 | 2019 | 86 | |
| 12 | 2020 | 68 | |
| 13 | 2011 | 65 | |
| 14 | 2014 | 63 | |
| 15 | 2014 | 57 | |
| 16 | 2014 | 57 | |
| 17 | 2020 | 55 | |
| 18 | 2019 | 52 | |
| 19 | 2014 | 49 | |
| 20 | 2013 | 48 |
About Yi Hu
Yi Hu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 313 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (46 papers), Lung Cancer Treatments and Mutations (43 papers), Lung Cancer Research Studies (29 papers), Cancer-related molecular mechanisms research (15 papers), Colorectal Cancer Treatments and Studies (13 papers), Lung Cancer Diagnosis and Treatment (13 papers), Ferroptosis and cancer prognosis (12 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (869 citations), Immunology (755 citations), Pulmonary and Respiratory Medicine (809 citations) and Molecular Biology (1.6k citations). Yi Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yangzhe Wu, Haitao Tao, Jinliang Wang, Shunchang Jiao, Yixue Xue, Yijia Li, Sujie Zhang, Zhibo Zhang, Jing Liu and Dan Chen. Their work appears in journals such as Frontiers in Oncology, Journal of Clinical Oncology, Cancer Medicine, Translational Lung Cancer Research and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.